MEGAN SCHERER: Open Payments
NPI 1467200220 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 29 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $143 |
| ABBVIE INC. | 4 | $81 |
| PFIZER INC. | 3 | $68 |
| Kowa Pharmaceuticals America, Inc. | 4 | $57 |
| Novo Nordisk Inc | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| Amgen Inc. | 2 | $35 |
| Exact Sciences Corporation | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
Products named: FARXIGA, NURTEC ODT, ZORYVE, VRAYLAR, JARDIANCE, BREZTRI, UBRELVY, TRELEGY ELLIPTA.
Industry payments across OH — which companies pay providers there.
